Inozyme Pharma Inc (INZY) Insider Trading

Total insider buys:
  • $29,502,161.78
Total insider sells:
  • $7,927,209.62
Most recent insider trade:
  • April 2, 2024
Most active insider trader:
  • Robert Lorne Hopfner
Trader NameDateTitleAmountPriceTypeTotal Value
April 2, 2024CEO7,523$6.94Sell$52,209.62
Aug. 1, 2023Director833,333$4.80Buy$3,999,998.40
May 11, 2023Director219,230$6.48Buy$1,420,610.40
March 29, 2023Director344,592$4.54Buy$1,564,447.68
March 27, 2023Director51,074$3.70Buy$188,973.80
Dec. 15, 2022COO21,500$1.39Buy$29,885.00
April 19, 2022CEO67,750$3.69Buy$249,997.50
April 19, 2022COO27,100$3.69Buy$99,999.00
April 19, 2022Major Shareholder1,355,000$3.69Buy$4,999,950.00
April 19, 2022Director1,070,000$3.69Buy$3,948,300.00
June 24, 2021CEO66,788$0.00Sell$0.00
Jan. 28, 2021Major Shareholder375,000$21.00Sell$7,875,000.00
July 28, 2020Director187,500$16.00Buy$3,000,000.00
July 28, 2020Major Shareholder625,000$16.00Buy$10,000,000.00
First«1 of 1»Last
  • Insiders are both buying and selling Inozyme Pharma Inc stock.

  • The insider traders at Inozyme Pharma Inc are: Robert Lorne Hopfner, Longitude Capital Partners Iii, Henric Bjorn Bjarke, Axel Bolte, Holdings A/S Novo, Douglas A Treco, and Pivotal Bioventure Partners Fu

  • The most active insider trader at Inozyme Pharma Inc is Robert Lorne Hopfner with 5 trades.

  • Holdings A/S Novo has sold the most Inozyme Pharma Inc stock with a total value of $15,750,000.00.

  • Longitude Capital Partners Iii has bought the most Inozyme Pharma Inc stock with a total value of $19,999,900.00.

  • The most recent insider trade for Inozyme Pharma Inc was on April 2, 2024.

  • The single biggest insider buy for Inozyme Pharma Inc was from Longitude Capital Partners Iii with a total value of $10,000,000.00 on July 28, 2020.

  • The single biggest insider sell for Inozyme Pharma Inc was from Holdings A/S Novo with a total value of $7,875,000.00 on Jan. 28, 2021.